News Major shareholder announcement – BlackRock, Inc. Staff September 11, 2023 Post Navigation Previous Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19 Next Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston More Stories Healthcare News HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference Staff December 23, 2024 Clinical Trial News Pharmaceutical Glaukos Submits New Drug Application to U.S. FDA for Epioxa™ Staff December 23, 2024 Cancer News Pharmaceutical The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids Staff December 23, 2024
